BOLT
Price
$0.79
Change
-$0.00 (-0.00%)
Updated
May 20 closing price
78 days until earnings call
XLO
Price
$1.25
Change
+$0.11 (+9.65%)
Updated
May 20 closing price
77 days until earnings call
Ad is loading...

BOLT vs XLO

Header iconBOLT vs XLO Comparison
Open Charts BOLT vs XLOBanner chart's image
Bolt Biotherapeutics
Price$0.79
Change-$0.00 (-0.00%)
Volume$254.72K
CapitalizationN/A
Xilio Therapeutics
Price$1.25
Change+$0.11 (+9.65%)
Volume$203.86K
CapitalizationN/A
View a ticker or compare two or three
BOLT vs XLO Comparison Chart

Loading...

BOLTDaily Signal changed days agoGain/Loss if shorted
 
Show more...
XLODaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
BOLT vs. XLO commentary
May 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BOLT is a Hold and XLO is a Hold.

COMPARISON
Comparison
May 21, 2024
Stock price -- (BOLT: $0.79 vs. XLO: $1.14)
Brand notoriety: BOLT and XLO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BOLT: 276% vs. XLO: 7%
Market capitalization -- BOLT: $30.23M vs. XLO: $42.08M
BOLT [@Biotechnology] is valued at $30.23M. XLO’s [@Biotechnology] market capitalization is $42.08M. The market cap for tickers in the [@Biotechnology] industry ranges from $586.12B to $0. The average market capitalization across the [@Biotechnology] industry is $2.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BOLT’s FA Score shows that 1 FA rating(s) are green whileXLO’s FA Score has 1 green FA rating(s).

  • BOLT’s FA Score: 1 green, 4 red.
  • XLO’s FA Score: 1 green, 4 red.
According to our system of comparison, XLO is a better buy in the long-term than BOLT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BOLT’s TA Score shows that 4 TA indicator(s) are bullish while XLO’s TA Score has 3 bullish TA indicator(s).

  • BOLT’s TA Score: 4 bullish, 6 bearish.
  • XLO’s TA Score: 3 bullish, 2 bearish.
According to our system of comparison, XLO is a better buy in the short-term than BOLT.

Price Growth

BOLT (@Biotechnology) experienced а -37.07% price change this week, while XLO (@Biotechnology) price change was -3.39% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.93%. For the same industry, the average monthly price growth was +5.91%, and the average quarterly price growth was +63.66%.

Reported Earning Dates

BOLT is expected to report earnings on Aug 07, 2024.

XLO is expected to report earnings on Aug 06, 2024.

Industries' Descriptions

@Biotechnology (+1.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for BOLT with price predictions.
OPEN
A.I.dvisor published
a Summary for XLO with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
XLO($42.1M) has a higher market cap than BOLT($30.2M). XLO YTD gains are higher at: 107.273 vs. BOLT (-29.205).
BOLTXLOBOLT / XLO
Capitalization30.2M42.1M72%
EBITDAN/AN/A-
Gain YTD-29.205107.273-27%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
BOLTXLO
RSI
ODDS (%)
Bullish Trend 1 day ago
75%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
67%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 9 days ago
72%
Bullish Trend 1 day ago
79%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
69%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
View a ticker or compare two or three
Ad is loading...
BOLTDaily Signal changed days agoGain/Loss if shorted
 
Show more...
XLODaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BTCM2.550.15
+6.25%
BIT Mining Limited
ITRI109.050.43
+0.40%
Itron
TH11.41-0.10
-0.87%
Target Hospitality Corp
BIDU110.58-2.01
-1.79%
Baidu
APPS2.49-0.10
-3.86%
Digital Turbine

XLO and

Correlation & Price change

A.I.dvisor tells us that XLO and CRMD have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that XLO and CRMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XLO
1D Price
Change %
XLO100%
+5.56%
CRMD - XLO
31%
Poorly correlated
-1.54%
AXON - XLO
31%
Poorly correlated
-0.57%
VKTX - XLO
30%
Poorly correlated
-2.98%
CERO - XLO
29%
Poorly correlated
-2.65%
CALA - XLO
28%
Poorly correlated
N/A
More